PS

Paramel Sivaprakasan Sathish Kumar

Director Director DIN 08296081
DIN 08296081 First appointment Oct 2018 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Oct 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Paramel Sivaprakasan Sathish Kumar

Data last updated:

Paramel Sivaprakasan Sathish Kumar was a Director at Mattathur Institute Of Medical Sciences And Research Centre Private Limited (2018–2020). The company operates in Healthcare.

DIN 08296081
Primary Designation Director
Industry Healthcare
First Appointment 12 Oct 2018

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Oct 20182014₹19.3 Lakh (FY 2019)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Mattathur Institute Of Medical Sciences And Research Centre Private Limited
Premium access

Shareholding and investment profile for Paramel Sivaprakasan Sathish Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Paramel Sivaprakasan Sathish Kumar

Paramel Sivaprakasan Sathish Kumar was first appointed on 12 Oct 2018 as Director at Mattathur Institute Of Medical Sciences And Research Centre Private Limited.

Paramel Sivaprakasan Sathish Kumar held 1 earlier board appointment: Mattathur Institute Of Medical Sciences And Research Centre Private Limited (Director, 12 Oct 2018 to 04 Mar 2020).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available